RxDoctor Payments Data

Ronald Kellum, MD

Family Medicine · Diamondhead, MSNPI 1679543102

Payments from drug & device makers

$645in general payments, 2019–2025

Across 30 payments — averaging $21.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$196
  • Pfizer$156
  • Johnson & Johnson$136
  • Sunovion Pharmaceuticals Inc.$50
  • Boehringer Ingelheim$27
  • Radius Health, Inc.$23
  • plus $57 from 3 others

What the payments were for

  • Food & beverage$61495%
  • Education$325%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$645 in reported general payments places this provider in the 50th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$56,840
Medicare patients
121
Services billed
817

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban38$50,599
OzempicSemaglutide24$28,808
JardianceEmpagliflozin15$24,622
XareltoRivaroxaban20$20,609
Combivent RespimatIpratropium/Albuterol Sulfate24$19,501
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$16,639
MounjaroTirzepatide18$16,210
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$10,308
MyrbetriqMirabegron12$8,194
Albuterol Sulfate HfaAlbuterol Sulfate87$3,271
Fluticasone-SalmeterolFluticasone Propion/Salmeterol19$2,557
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$2,249
Atorvastatin Calcium288$2,221
Wixela InhubFluticasone Propion/Salmeterol14$2,143
Celecoxib61$1,878

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$156$50,59938 claims
Boehringer IngelheimJardiance, Combivent Respimat$27$44,12439 claims
Johnson & JohnsonXarelto$136$20,60920 claims
AstraZenecaBreztri Aerosphere$17$16,63915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Diamondhead

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →